Navigation Links
Scioderm, Inc. Named a 2013 "Fierce Top 15" Company by FierceBiotech
Date:9/24/2013

DURHAM, N.C., Sept. 24, 2013 /PRNewswire/ -- Scioderm, Inc., a biopharmaceutical company focused on the development of innovative therapies for treating rare diseases with high unmet need, has been selected by FierceBiotech as one of their "Fierce 15" for 2013. The "Fierce 15" is FierceBiotech's annual list of the top 15 emerging companies in the biotech industry, thus designating Scioderm, Inc. as one of the most promising private biotechnology companies in the industry. This is FierceBiotech's eleventh annual "Fierce 15" selection.

"In record time Scioderm has posted promising early efficacy data on a therapy for a rare and terrible disease, garnered a significant round of venture cash, earned a coveted breakthrough therapy designation at the FDA for its therapy and now plans to mount a critical trial in coming months," says John Carroll, editor of FierceBiotech. "In many ways Scioderm epitomizes what we mean by the word 'fierce.'"

"We are proud to join this prestigious group of innovative companies and for our team's recognition as a Fierce 15 Company," said Robert Ryan., Ph.D., President and Chief Executive Officer of Scioderm.  "There is a tremendous need for novel treatment options for treating the debilitating skin effects in patients with Epidermolysis Bullosa. The Scioderm team is working passionately to provide patients a new therapeutic alternative, in a disease with no currently effective treatments."

The Fierce 15 celebrates the spirit of being "fierce" – championing innovation and creativity, even in the face of intense competition.

An internationally recognized daily newsletter reaching more than 100,000 biotech and pharma industry professionals, FierceBiotech provides subscribers with an authoritative analysis of the day's top stories. Every year FierceBiotech evaluates hundreds of private companies from around
'/>"/>

SOURCE Scioderm
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Moderna Therapeutics Named a "Fierce 15" Biotech Company for 2013
2. TriCore Reference Laboratories Named First Next-Generation Sequencing Center of Excellence by Life Technologies
3. Andresen, McManamon, Willner Named Winners of SPIE Directors' and President's Awards
4. Luke Bradshaw Named CryoScience Global Marketing & Sales Manager for the Americas at Taylor-Wharton
5. Express Diagnostics Named to the Inc. 5000 List of Fastest-Growing Companies
6. Bayer CropScience Cotton Belt Challenge Winners Named
7. SynteractHCR Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
8. Core and More Technologies Named Among Top 10 Best Internet Marketing Agencies in U.S.
9. Newlight Named Most Innovative Company of the Year
10. BioLife Solutions Named One of Washingtons Best Companies
11. Syngentas Mary-Dell Chilton named 2013 World Food Prize laureate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent ... viruses is the Epstein Barr Virus (EBV), and one of ... a chronic inflammatory disease that destroys the body’s joints. As ... have high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... BURLINGAME, Calif. , Jan. 14, 2014 As pet owners ... no doubt many of them wrote: "Take better care of my ... and even designer clothes and top-brand carrying cases to take the ... Pet parents might also feel compelled to buy some pricey toys ...
(Date:1/14/2014)... In recent years, growing suspicion about the ... development and promotion has led to unprecedented levels of ... concerns about the insidious impact of commercialization of research, ... to the world’s biggest pharmas for illegal marketing activities, ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... Session Highlights New Small Molecule Drug ... ... Inc.,(Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing,therapeutics for the ... and mechanism of action data for,its selective kinase inhibitor, ENMD-2076. On ...
... (Nasdaq: IMRX ) today announced that it received ... that for the last 30,consecutive business days, the bid ... share. As a result, the company fails to comply ... forth in,Marketplace Rule 4310(c)(4)., In accordance with Marketplace ...
... SGN ) has confirmed that it has filed ... Officer, Dr. Lowell T. Harmison, has,scheduled a webcast on ... Harmison stated: "Now that Signalife has closed filing the,company,s ... I am pleased to provide direction on new contracts, ...
Cached Biology Technology:EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session 2EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session 3ImaRx Therapeutics Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQ's Minimum Bid Price Requirement 2Signalife Announces Webcast 2Signalife Announces Webcast 3
(Date:7/9/2014)... can alleviate the symptoms of Alzheimer,s disease, ... and effectively scavenge amyloid beta peptide in ... reduced and eliminated Aβ deposition in an ... significantly improved behavioral and cognitive impairment. Dr. ... Hospital of China Medical University, China immunized ...
(Date:7/9/2014)... cancer patients with high levels of vitamin D in their ... shows. , Patients with the highest levels of vitamin ... with the lowest levels, the findings reveal. , The study ... D in bowel cancer patients after their diagnosis which ... from dietary sources with their long term survival prospects. ...
(Date:7/9/2014)... first make a copy of its DNA, a fundamental step ... times a day in the human body. While scientists have ... to replicate DNAthe enzymes that unzip the double-stranded DNA and ... how the process works. , Now, researchers at Rockefeller University ... on at the "replication fork"the point where DNA is split ...
Breaking Biology News(10 mins):Rockefeller scientists first to reconstitute the DNA 'replication fork' 2Rockefeller scientists first to reconstitute the DNA 'replication fork' 3Rockefeller scientists first to reconstitute the DNA 'replication fork' 4
... German . It would appear reasonable to assume ... blueprints. However, scientists from the Max Planck Institute for Developmental ... team have now decoded, for the first time, the entire ... a close relative of the thale cress ( Arabidopsis thaliana ...
... at the Keck School of Medicine of the University ... the first time that the human placenta plays an ... new treatment strategies that could mitigate health impacts such ... findings, conducted with researchers from Vanderbilt University as part ...
... , Berkeley In a new study suggesting pesticides ... researchers at the University of California, Berkeley,s School of Public ... widely used on food crops is related to lower ... that every tenfold increase in measures of organophosphates detected during ...
Cached Biology News:Evolution can cause a rapid reduction in genome size 2Evolution can cause a rapid reduction in genome size 3USC research shows critical role of placenta in brain development 2Prenatal pesticide exposure tied to lower IQ in children 2Prenatal pesticide exposure tied to lower IQ in children 3Prenatal pesticide exposure tied to lower IQ in children 4